SVP and Chief Technical Officer Michael J. Labarre sold $509K of Halozyme Therapeutics, Inc.

Sold$509,075

$23.80Price

21,387Shares

−11%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Wed, May 20. Filed Thu, May 21, 12:11 PM ET, during the session. Not investment advice.